Click on image to view larger version.

Fig. 7. Dominant-negative SH3* CrkII abrogates ephrin-A5-mediated
cytoskeletal changes. EphA3 293T cells (control) were transiently transfected
with myc-tagged, w/t CrkII, dominant-negative SH3* CrkII or both
w/t and SH3* CrkII as indicated. Parallel cultures of stimulated
(+) or nonstimulated (-) cells were fixed in 4% PFA. Cells were stained with
rhodamine-phalloidin (Phalloidin) or anti-Myc antibody (anti-Myc) to monitor
the actin cytoskeleton or CrkII derived proteins, respectively.